ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+5%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$413M
AUM Growth
+$413M
(+6.5%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
8.59%
Top 10 Holdings %
Top 10 Hldgs %
62.35%
Holding
38
New
8
Increased
6
Reduced
6
Closed
5
Top Buys
| 1 |
Nuvation Bio
NUVB
|
$20.9M |
| 2 |
Viridian Therapeutics
VRDN
|
$11.4M |
| 3 |
CureVac
CVAC
|
$10.1M |
| 4 |
Bolt Biotherapeutics
BOLT
|
$9.47M |
| 5 |
ESSA Pharma
EPIX
|
$8.28M |
Top Sells
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$11.9M |
| 2 |
Castle Biosciences
CSTL
|
$7.53M |
| 3 |
Vir Biotechnology
VIR
|
$7.37M |
| 4 |
Atea Pharmaceuticals
AVIR
|
$6.98M |
| 5 |
Pulmonx
LUNG
|
$6.41M |
Sector Composition
| 1 | Healthcare | 97.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $55.8M | 10.7% | 903,688 -113,000 | -11% | -$6.98M |
|
|
MDVL
2
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $40.9M | 7.84% | 2,920,780 | – | – |
|
|
CERE
3
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $23.7M | 4.55% | 1,728,590 -38,850 | -2% | -$533K |
|
|
SYRS
4
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $23.5M | 4.5% | 3,139,895 +497,395 | +19% | +$3.72M |
|
5
Fate Therapeutics
FATE
$120M
| $22.3M | 4.27% | 270,000 +10,000 | +4% | +$825K |
|
6
Natera
NTRA
$23.1B
| $22.1M | 4.24% | 218,000 +30,000 | +16% | +$3.05M |
|
|
7
Nuvation Bio
NUVB
$1.02B
| $20.9M | 4.01% | +2,000,000 | New | +$20.9M |
|
8
Intellia Therapeutics
NTLA
$1.22B
| $18.1M | 3.46% | 225,000 | – | – |
|
9
Repligen
RGEN
$6.88B
| $16M | 3.08% | 82,500 | – | – |
|
10
Cogent Biosciences
COGT
$1.69B
| $14.2M | 2.73% | 1,622,591 | – | – |
|
11
Iovance Biotherapeutics
IOVA
$807M
| $12.9M | 2.47% | 406,986 +46,986 | +13% | +$1.49M |
|
|
12
Viridian Therapeutics
VRDN
$1.5B
| $11.4M | 2.18% | +680,768 | New | +$11.4M |
|
13
iTeos Therapeutics
ITOS
| $11M | 2.12% | 322,794 | – | – |
|
|
14
ESSA Pharma
EPIX
$11.4M
| $10.6M | 2.02% | 363,185 +285,000 | +365% | +$8.28M |
|
15
Oric Pharmaceuticals
ORIC
$994M
| $10.1M | 1.94% | 413,061 | – | – |
|
|
16
CureVac
CVAC
$1.21B
| $10.1M | 1.93% | +110,000 | New | +$10.1M |
|
17
Apellis Pharmaceuticals
APLS
$3.48B
| $9.87M | 1.89% | 230,000 | – | – |
|
|
18
Bolt Biotherapeutics
BOLT
$9.85M
| $9.47M | 1.82% | +287,725 | New | +$9.47M |
|
|
APTO
19
DELISTED
Aptose Biosciences, Inc.
APTO
| $8.42M | 1.61% | 1,409,150 | – | – |
|
|
OLK
20
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $7.2M | 1.38% | +200,000 | New | +$7.2M |
|
21
Arvinas
ARVN
$568M
| $6.89M | 1.32% | 104,253 +4,253 | +4% | +$281K |
|
|
22
Castle Biosciences
CSTL
$696M
| $6.85M | 1.31% | 100,000 -110,000 | -52% | -$7.53M |
|
|
ITMR
23
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $6.55M | 1.26% | 273,569 -228,395 | -46% | -$5.47M |
|
24
4D Molecular Therapeutics
FDMT
$288M
| $6.51M | 1.25% | 150,000 | – | – |
|
25
ARS Pharmaceuticals
SPRY
$1.15B
| $5.61M | 1.08% | 128,572 | – | – |
|